Abstract
This article investigates to what extent patient advocacy organisations play a role in influencing R&D and
policymaking for rare neuromuscular diseases. The Dutch neuromuscular disease organisation VSN is
studied in depth. A brief history of the VSN is sketched along with the international embedding of the
organisation. Then, a more general perspective is
... read more